Potential of Antineoplastons in Diseases of Old Age
- 1 January 1995
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 7 (3), 157-167
- https://doi.org/10.2165/00002512-199507030-00001
Abstract
No abstract availableThis publication has 97 references indexed in Scilit:
- Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membraneNature, 1994
- NGF and the Treatment of Alzheimer's DiseaseExperimental Neurology, 1993
- The Inhibitory Effect of the Combination of Antineoplaston A‐10 Injection with a Small Dose of cis‐Diamminedichloroplatinum on Cell and Tumor Growth of Human Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1992
- Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unitCell, 1992
- Interferon in combination with antitumourigenic phenyl derivatives: potentiation of IFNα activity in‐vitroBritish Journal of Haematology, 1991
- Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185
erb
B2
Science, 1990
- Glutamine derivatives as novel anticancer agents acting via gastrin binding sitesMedical Hypotheses, 1990
- Inhibitory effect of antineoplaston A-10 on breast cancer transplanted to athymic mice and human hepatocellular carcinoma cell lines.The Kurume Medical Journal, 1990
- Actions of an endogenous antitumorigenic agent on mammary tumor development and modeling analysis of its capacity for interacting with DNAJournal of Steroid Biochemistry, 1988
- Investigations on unknown ninhydrin-reacting substances in human blood serum. I. Attempts at identification of three such substancesCellular and Molecular Life Sciences, 1969